{"disease":{"id":"tce-rrmm","name":"tce rrmm"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07320326","title":"ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":159,"lead_sponsor_name":"Peking University People's Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}